CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $45,000 | -15.1% | 1,000 | 0.0% | 0.02% | -5.9% |
| Q1 2018 | $53,000 | -23.2% | 1,000 | -1.5% | 0.02% | -22.7% |
| Q4 2017 | $69,000 | -24.2% | 1,015 | -7.7% | 0.02% | -26.7% |
| Q3 2017 | $91,000 | -12.5% | 1,100 | -1.3% | 0.03% | -23.1% |
| Q2 2017 | $104,000 | -26.2% | 1,115 | -49.7% | 0.04% | -29.1% |
| Q1 2017 | $141,000 | +43.9% | 2,215 | 0.0% | 0.06% | +34.1% |
| Q4 2016 | $98,000 | -44.0% | 2,215 | -54.5% | 0.04% | -46.8% |
| Q3 2016 | $175,000 | +161.2% | 4,865 | 0.0% | 0.08% | +148.4% |
| Q2 2016 | $67,000 | +31.4% | 4,865 | +81.8% | 0.03% | +10.7% |
| Q1 2016 | $51,000 | -42.7% | 2,676 | +5.5% | 0.03% | -45.1% |
| Q4 2015 | $89,000 | -21.9% | 2,536 | +104.0% | 0.05% | -29.2% |
| Q3 2015 | $114,000 | +12.9% | 1,243 | +8.1% | 0.07% | +16.1% |
| Q2 2015 | $101,000 | – | 1,150 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $25,940,177,000 | 18.86% |
| Boxer Capital, LLC | 1,000,000 | $63,670,000 | 13.91% |
| Palo Alto Investors LP | 3,894,963 | $247,992,000 | 11.72% |
| Consonance Capital Management LP | 1,334,467 | $84,966,000 | 8.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 150,000 | $9,551,000 | 4.70% |
| Crosspoint Capital Strategies, LLC | 82,761 | $5,269,000 | 4.42% |
| Redmile Group, LLC | 972,696 | $61,932,000 | 4.02% |
| Avoro Capital Advisors LLC | 353,900 | $22,533,000 | 2.88% |
| Ghost Tree Capital, LLC | 200,000 | $12,734,000 | 2.37% |
| Partner Investment Management, L.P. | 21,837 | $1,390,000 | 1.69% |